Comorbid Diabetes and Severe Mental Illness: Outcomes in an Integrated Health Care Delivery System

[1]  J. Morales,et al.  The 2018 update of the American College of Physicians glycaemic management recommendations: An invitation to continued inertia? , 2018, Diabetes, obesity & metabolism.

[2]  E. Vittinghoff,et al.  Diabetes and Prediabetes Prevalence by Race and Ethnicity Among People With Severe Mental Illness , 2018, Diabetes Care.

[3]  T. Cundy,et al.  Adherence to medication, glycaemic control and hospital attendance in young adults with type 2 diabetes , 2018, Internal medicine journal.

[4]  H. Pincus,et al.  The Case for Severe Mental Illness as a Disparities Category. , 2018, Psychiatric services.

[5]  Introduction: Standards of Medical Care in Diabetes—2018 , 2017, Diabetes Care.

[6]  D. Vancampfort,et al.  Are people with schizophrenia adherent to diabetes medication? A comparative meta-analysis , 2017, Psychiatry Research.

[7]  O. Mors,et al.  Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study. , 2017, The American journal of psychiatry.

[8]  E. Vittinghoff,et al.  Diabetes Screening among Antipsychotic-Treated Adults with Severe Mental Illness in an Integrated Delivery System: A Retrospective Cohort Study , 2017, Journal of General Internal Medicine.

[9]  D. Schillinger,et al.  Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review , 2016, Journal of General Internal Medicine.

[10]  E. Vittinghoff,et al.  Diabetes Screening Among Underserved Adults With Severe Mental Illness Who Take Antipsychotic Medications. , 2015, JAMA internal medicine.

[11]  John Q. Young,et al.  Prevalence of behavioral health disorders and associated chronic disease burden in a commercially insured health system: findings of a case-control study. , 2015, General hospital psychiatry.

[12]  D. Bradford,et al.  Health Disparities in Quality Indicators of Healthcare Among Adults with Mental Illness , 2014 .

[13]  Judith A. Long,et al.  Glucose Control and Medication Adherence Among Veterans With Diabetes and Serious Mental Illness: Does Collocation of Primary Care and Mental Health Care Matter? , 2014, Diabetes Care.

[14]  V. Basevi,et al.  Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.

[15]  F. Dickerson,et al.  A comparison of adherence to hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness , 2011, Psychiatry Research.

[16]  Dean Schillinger,et al.  Language Barriers, Physician-Patient Language Concordance, and Glycemic Control Among Insured Latinos with Diabetes: The Diabetes Study of Northern California (DISTANCE) , 2010, Journal of General Internal Medicine.

[17]  Kirsten Bibbins-Domingo,et al.  Projected effect of dietary salt reductions on future cardiovascular disease. , 2010, The New England journal of medicine.

[18]  L. Dixon,et al.  Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia? , 2010, Schizophrenia bulletin.

[19]  Daniel M. Hartung,et al.  Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. , 2010, Archives of general psychiatry.

[20]  J. Lieberman,et al.  Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state. , 2009, Psychiatric services.

[21]  Julie A Schmittdiel,et al.  The effectiveness of diabetes care management in managed care. , 2009, The American journal of managed care.

[22]  I. Nazareth,et al.  Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: Systematic review and metaanalysis , 2008, BMC psychiatry.

[23]  C. Blanchette,et al.  Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage. , 2008, Health services research.

[24]  M. Valenstein,et al.  Diabetes treatment among VA patients with comorbid serious mental illness. , 2006, Psychiatric services.

[25]  F. Dickerson,et al.  Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. , 2006, The Journal of nervous and mental disease.

[26]  Craig W. Colton,et al.  Congruencies in Increased Mortality Rates, Years of Potential Life Lost, and Causes of Death Among Public Mental Health Clients in Eight States , 2006, Preventing chronic disease.

[27]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[28]  Donald R. Miller,et al.  Disparities in diabetes care: impact of mental illness. , 2005, Archives of internal medicine.

[29]  E. Ford.  Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. , 2005, Diabetes care.

[30]  J. Newcomer.  Second-Generation (Atypical) Antipsychotics and Metabolic Effects , 2005, CNS drugs.

[31]  G. Zou,et al.  A modified poisson regression approach to prospective studies with binary data. , 2004, American journal of epidemiology.

[32]  B. Druss,et al.  Mental disorders and use of cardiovascular procedures after myocardial infarction. , 2000, JAMA.